These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2458874)

  • 41. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
    Shenouda G; Thomson DM
    Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D; Kaufmann M; Drings P; Fedra G
    Oncology; 1978; 35(6):242-5. PubMed ID: 370704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
    Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
    Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of leukocyte adherence inhibition (LAI) test in primary and secondary hepatic malignancies.
    Tantry BV; Jain AK; Gupta S; Gupta JP
    J Surg Oncol; 1984 Nov; 27(3):159-62. PubMed ID: 6092784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
    Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
    Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A coded study of antitumor immunity to human lung cancer assayed by tube leukocyte adherence inhibition.
    Thomson DM; Ayeni RO; MacFarlane JK; Tataryn DN; Terrin M; Schraufnagel D; Wilson J; Mulder DS
    Ann Thorac Surg; 1981 Apr; 31(4):314-21. PubMed ID: 6260045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
    Fujisawa T; Waldman SR; Yonemoto RH
    Cancer; 1977 Feb; 39(2):506-13. PubMed ID: 65207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leukocyte adherence inhibition assay in immunodiagnosis of colon cancers.
    Cavallini G; Berti G; Tioli P
    Ital J Surg Sci; 1984; 14(4):281-8. PubMed ID: 6398321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF).
    Harding MW; Yang TJ
    Cell Immunol; 1984 Aug; 87(1):206-16. PubMed ID: 6204773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leukocyte adherence inhibition test in lung cancer immunodiagnostic detection.
    Lodi M; Cavallini G; Pampolini M
    Ital J Surg Sci; 1988; 18(1):25-34. PubMed ID: 2836338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An evaluation of leucocyte adherence inhibition microassay using colorectal cancer cell lines.
    Machida S; Yamauchi M; Sato M; Ishioka T; Takashima K; Nishikawa T; Fukushima M; Koie H
    Gan; 1980 Jun; 71(3):387-92. PubMed ID: 6998824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukocyte adherence inhibition microtest for the detection of cell-mediated immunity to tumor in gastric cancer patients.
    Koyama S; Sakita T; Fukutomi H; Kawakita I; Tamura N
    Oncology; 1981; 38(1):13-7. PubMed ID: 7003459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
    Onji M
    Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LAI reactivity in rats immunized with tumor cells.
    Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
    Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats.
    Kalafut F; Klobusická M; Novotná L
    Neoplasma; 1984; 31(5):507-13. PubMed ID: 6390225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes.
    Thomson DM; Phelan K; Morton DG; Bach MK
    Int J Cancer; 1982 Sep; 30(3):299-306. PubMed ID: 7129679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.